Abnormal 0 8 0 8 B-clinical_variable
serum 9 14 9 14 I-clinical_variable
thyroid 15 22 15 22 I-clinical_variable
- 22 23 22 23 I-clinical_variable
stimulating 23 34 23 34 I-clinical_variable
hormone(TSH 35 46 35 46 I-clinical_variable
) 46 47 46 47 I-clinical_variable
HbA1c 48 53 48 53 B-clinical_variable
> 54 55 54 55 O
8.5 55 58 55 58 B-lower_bound
% 58 59 58 59 I-lower_bound
( 60 61 60 61 O
> 61 62 61 62 O
69 62 64 62 64 B-lower_bound
mmol 65 69 65 69 I-lower_bound
/ 69 70 69 70 I-lower_bound
mol 70 73 70 73 I-lower_bound
) 73 74 73 74 O

Absence 0 7 75 82 O
of 8 10 83 85 O
medically 11 20 86 95 O
approved 21 29 96 104 O
contraception 30 43 105 118 O
in 44 46 119 121 O
females 47 54 122 129 B-gender
of 55 57 130 132 O
childbearing 58 70 133 145 O
potential[exempli 71 88 146 163 O
gratia 89 95 164 170 O
( 96 97 171 172 O
e.g. 97 101 172 176 O
) 101 102 176 177 O
, 102 103 177 178 O
hysterectomy 104 116 179 191 O
, 116 117 191 192 O
oral 118 122 193 197 O
contraceptive 123 136 198 211 O
medications 137 148 212 223 O
, 148 149 223 224 O
intrauterine 149 161 224 236 O
device 162 168 237 243 O
combined 169 177 244 252 O
with 178 182 253 257 O
a 183 184 258 259 O
barrier 185 192 260 267 O
method 193 199 268 274 O
, 199 200 274 275 O
two 201 204 276 279 O
( 205 206 280 281 O
2 206 207 281 282 O
) 207 208 282 283 O
combined 209 217 284 292 O
barrier 218 225 293 300 O
methods 226 233 301 308 O
such 234 238 309 313 O
as 239 241 314 316 O
diaphragm 242 251 317 326 O
and 252 255 327 330 O
condom 256 262 331 337 O
or 263 265 338 340 O
spermicide 266 276 341 351 O
, 276 277 351 352 O
or 278 280 353 355 O
condom 281 287 356 362 O
and 288 291 363 366 O
spermicide 292 302 367 377 O
; 302 303 377 378 O
bilateral 304 313 379 388 O
tubal 314 319 389 394 O
ligation 320 328 395 403 O
and 329 332 404 407 O
vasectomy 333 342 408 417 O
are 343 346 418 421 O
acceptable 347 357 422 432 O
contraceptive 358 371 433 446 O
methods 372 379 447 454 O
when 380 384 455 459 O
combined 385 393 460 468 O
with 394 398 469 473 O
another 399 406 474 481 O
single 407 413 482 488 O
method 414 420 489 495 O
from 421 425 496 500 O
above 426 431 501 506 O
] 431 432 506 507 O

Administration 0 14 508 522 O
of 15 17 523 525 O
Prototype 18 27 526 535 B-treatment
2 28 29 536 537 I-treatment
( 30 31 538 539 I-treatment
GSP2 31 35 539 543 I-treatment
) 35 36 543 544 I-treatment
, 36 37 544 545 O
Prototype 38 47 546 555 B-treatment
3 48 49 556 557 I-treatment
( 50 51 558 559 I-treatment
GSP3 51 55 559 563 I-treatment
) 55 56 563 564 I-treatment
, 56 57 564 565 O
Gelesis100,or 58 71 566 579 B-treatment
Gelesis200 72 82 580 590 B-treatment
in 83 85 591 593 O
a 86 87 594 595 O
previous 88 96 596 604 O
study 97 102 605 610 O

Angina 0 6 611 617 B-chronic_disease
, 6 7 617 618 O
coronary 8 16 619 627 B-treatment
bypass 17 23 628 634 I-treatment
, 23 24 634 635 O
or 25 27 636 638 O
myocardial 28 38 639 649 B-chronic_disease
infarction 39 49 650 660 I-chronic_disease
within 50 56 661 667 O
six(6)months 57 69 668 680 B-upper_bound
prior 70 75 681 686 I-upper_bound
to 76 78 687 689 O
Screening 79 88 690 699 O
Visit 89 94 700 705 O

Antidiabetic 0 12 706 718 B-treatment
medications 13 24 719 730 I-treatment
within 25 31 731 737 O
one 32 35 738 741 B-upper_bound
( 36 37 742 743 I-upper_bound
1 37 38 743 744 I-upper_bound
) 38 39 744 745 I-upper_bound
month 40 45 746 751 I-upper_bound
prior 46 51 752 757 I-upper_bound
to 52 54 758 760 O
Screening 55 64 761 770 O
Visit 65 70 771 776 O
[ 71 72 777 778 O
except 72 78 778 784 O
stable 79 85 785 791 O
doses 86 91 792 797 O
of 92 94 798 800 O
metformin 95 104 801 810 B-treatment
and 105 108 811 814 O
DPP-4 109 114 815 820 B-treatment
inhibitors 115 125 821 831 I-treatment
for 126 129 832 835 O
at 130 132 836 838 O
least 133 138 839 844 O
one 139 142 845 848 O
( 143 144 849 850 O
1 144 145 850 851 O
) 145 146 851 852 O
month 147 152 853 858 O
in 153 155 859 861 O
subjects 156 164 862 870 O
with 165 169 871 875 O
Type 170 174 876 880 B-chronic_disease
2 175 176 881 882 I-chronic_disease
Diabetes 177 185 883 891 I-chronic_disease
] 185 186 891 892 O

Any 0 3 893 896 O
other 4 9 897 902 O
medication 10 20 903 913 O
known 21 26 914 919 O
to 27 29 920 922 O
cause 30 35 923 928 O
weight 36 42 929 935 O
loss 43 47 936 940 O
or 48 50 941 943 O
weight 51 57 944 950 O
gain 58 62 951 955 O
within 63 69 956 962 O
one 70 73 963 966 B-upper_bound
( 74 75 967 968 I-upper_bound
1 75 76 968 969 I-upper_bound
) 76 77 969 970 I-upper_bound
month 78 83 971 976 I-upper_bound
prior 84 89 977 982 I-upper_bound
to 90 92 983 985 O
Screening 93 102 986 995 O
Visit 103 108 996 1001 O

Blood 0 5 1002 1007 B-treatment
transfusion 6 17 1008 1019 I-treatment
within 18 24 1020 1026 O
three 25 30 1027 1032 O
( 31 32 1033 1034 B-upper_bound
3 32 33 1034 1035 I-upper_bound
) 33 34 1035 1036 I-upper_bound
months 35 41 1037 1043 I-upper_bound
prior 42 47 1044 1049 I-upper_bound
to 48 50 1050 1052 O
Screening 51 60 1053 1062 O
Visit 61 66 1063 1068 O

Body 0 4 1069 1073 B-clinical_variable
Mass 5 9 1074 1078 I-clinical_variable
Index 10 15 1079 1084 I-clinical_variable
( 16 17 1085 1086 I-clinical_variable
BMI 17 20 1086 1089 I-clinical_variable
) 20 21 1089 1090 I-clinical_variable
≥27 22 25 1091 1094 O
and 26 29 1095 1098 O
≤40 30 33 1099 1102 O
kilogram 34 42 1103 1111 I-upper_bound
( 43 44 1112 1113 I-upper_bound
kg)/meter 44 53 1113 1122 I-upper_bound
( 54 55 1123 1124 I-upper_bound
M)2 55 58 1124 1127 I-upper_bound

Change 0 6 1128 1134 O
in 7 9 1135 1137 O
medications 10 21 1138 1149 O
treating 22 30 1150 1158 O
dyslipidemia 31 43 1159 1171 B-chronic_disease
within 44 50 1172 1178 O
one 51 54 1179 1182 B-upper_bound
( 55 56 1183 1184 I-upper_bound
1 56 57 1184 1185 I-upper_bound
) 57 58 1185 1186 I-upper_bound
month 59 64 1187 1192 I-upper_bound
prior 65 70 1193 1198 I-upper_bound
to 71 73 1199 1201 O
Screening 74 83 1202 1211 O
Visit 84 89 1212 1217 O

Change 0 6 1218 1224 O
in 7 9 1225 1227 O
medications 10 21 1228 1239 B-treatment
treating 22 30 1240 1248 O
hypertension 31 43 1249 1261 B-chronic_disease
within 44 50 1262 1268 O
one 51 54 1269 1272 B-upper_bound
( 55 56 1273 1274 I-upper_bound
1 56 57 1274 1275 I-upper_bound
) 57 58 1275 1276 I-upper_bound
month 59 64 1277 1282 I-upper_bound
prior 65 70 1283 1288 I-upper_bound
to 71 73 1289 1291 O
Screening 74 83 1292 1301 O
Visit 84 89 1302 1307 O

Diabetic 0 8 1308 1316 B-chronic_disease
subjects 9 17 1317 1325 O

Fasting 0 7 1326 1333 B-clinical_variable
serum 8 13 1334 1339 I-clinical_variable
insulin 14 21 1340 1347 I-clinical_variable
< 22 23 1348 1349 O
24 23 25 1349 1351 B-upper_bound
microunit 26 35 1352 1361 I-upper_bound
( 36 37 1362 1363 I-upper_bound
µU)/milliliter 37 51 1363 1377 I-upper_bound
( 52 53 1378 1379 I-upper_bound
mL)at 53 58 1379 1384 I-upper_bound
both 59 63 1385 1389 O
Screening 64 73 1390 1399 O
Visits 74 80 1400 1406 O
in 81 83 1407 1409 O
normoglycemic 84 97 1410 1423 O
subjects 98 106 1424 1432 O
Ability 107 114 1433 1440 O
to 115 117 1441 1443 O
follow 118 124 1444 1450 O
verbal 125 131 1451 1457 O
and 132 135 1458 1461 O
written 136 143 1462 1469 O
instructions 144 156 1470 1482 O
Consent 157 164 1483 1490 O
obtained 165 173 1491 1499 O
via 174 177 1500 1503 O
signed 178 184 1504 1510 O
ICF 185 188 1511 1514 O

History 0 7 1515 1522 O
of 8 10 1523 1525 O
abdominal 11 20 1526 1535 B-treatment
radiation 21 30 1536 1545 I-treatment
treatment 31 40 1546 1555 I-treatment

History 0 7 1556 1563 O
of 8 10 1564 1566 O
cancer 11 17 1567 1573 B-cancer
within 18 24 1574 1580 O
the 25 28 1581 1584 O
past 29 33 1585 1589 B-upper_bound
five(5 34 40 1590 1596 I-upper_bound
) 40 41 1596 1597 I-upper_bound
years 42 47 1598 1603 I-upper_bound

History 0 7 1604 1611 O
of 8 10 1612 1614 O
eating 11 17 1615 1621 B-chronic_disease
disorders 18 27 1622 1631 I-chronic_disease
including 28 37 1632 1641 O
binge 38 43 1642 1647 O
eating 44 50 1648 1654 O
( 51 52 1655 1656 O
except 52 58 1656 1662 O
for 59 62 1663 1666 O
mild 63 67 1667 1671 O
binge 68 73 1672 1677 O
eating)or 74 83 1678 1687 O
emesis 84 90 1688 1694 B-clinical_variable
≥2 91 93 1695 1697 O
/ 93 94 1697 1698 I-lower_bound
week 94 98 1698 1702 I-lower_bound
from 99 103 1703 1707 O
any 104 107 1708 1711 O
cause 108 113 1712 1717 O
Weight 114 120 1718 1724 B-clinical_variable
change 121 127 1725 1731 I-clinical_variable
> 128 129 1732 1733 O
3 129 130 1733 1734 B-lower_bound
% 130 131 1734 1735 I-lower_bound
within 132 138 1736 1742 O
three(3 139 146 1743 1750 O
) 146 147 1750 1751 O
months 148 154 1752 1758 O
prior 155 160 1759 1764 O
to 161 163 1765 1767 O
and 164 167 1768 1771 O
during 168 174 1772 1778 O
the 175 178 1779 1782 O
Screening 179 188 1783 1792 O
period 189 195 1793 1799 O

History 0 7 1800 1807 O
of 8 10 1808 1810 O
gastric 11 18 1811 1818 B-treatment
bypass 19 25 1819 1825 I-treatment
or 26 28 1826 1828 O
any 29 32 1829 1832 O
other 33 38 1833 1838 O
gastric 39 46 1839 1846 B-treatment
surgery 47 54 1847 1854 I-treatment

History 0 7 1855 1862 O
of 8 10 1863 1865 O
gastric 11 18 1866 1873 B-chronic_disease
or 19 21 1874 1876 I-chronic_disease
duodenal 22 30 1877 1885 I-chronic_disease
ulcer 31 36 1886 1891 I-chronic_disease

History 0 7 1892 1899 O
of 8 10 1900 1902 O
hepatitis 11 20 1903 1912 B-chronic_disease
B 21 22 1913 1914 I-chronic_disease
or 23 25 1915 1917 I-chronic_disease
C 26 27 1918 1919 I-chronic_disease
History 28 35 1920 1927 B-chronic_disease
of 36 38 1928 1930 I-chronic_disease
human 39 44 1931 1936 I-chronic_disease
immunodeficiency 45 61 1937 1953 I-chronic_disease
virus(HIV 62 71 1954 1963 I-chronic_disease
) 71 72 1963 1964 I-chronic_disease

History 0 7 1965 1972 O
of 8 10 1973 1975 O
intestinal 11 21 1976 1986 B-chronic_disease
obstruction 22 33 1987 1998 I-chronic_disease
or 34 36 1999 2001 O
high 37 41 2002 2006 O
risk 42 46 2007 2011 O
of 47 49 2012 2014 O
intestinal 50 60 2015 2025 O
obstruction 61 72 2026 2037 O
, 72 73 2037 2038 O
including 73 82 2038 2047 O
suspected 83 92 2048 2057 O
small 93 98 2058 2063 B-chronic_disease
bowel 99 104 2064 2069 I-chronic_disease
adhesions 105 114 2070 2079 O

History 0 7 2080 2087 O
of 8 10 2088 2090 O
intestinal 11 21 2091 2101 B-chronic_disease
stricture 22 31 2102 2111 I-chronic_disease
( 32 33 2112 2113 O
e.g. 33 37 2113 2117 O
, 37 38 2117 2118 O
Crohn 39 44 2119 2124 B-chronic_disease
's 44 46 2124 2126 I-chronic_disease
disease 47 54 2127 2134 I-chronic_disease
) 54 55 2134 2135 O

History 0 7 2136 2143 O
of 8 10 2144 2146 O
pancreatitis 11 23 2147 2159 B-chronic_disease
within 24 30 2160 2166 O
the 31 34 2167 2170 O
past 35 39 2171 2175 B-upper_bound
12 40 42 2176 2178 I-upper_bound
months 43 49 2179 2185 I-upper_bound

History 0 7 2186 2193 O
of 8 10 2194 2196 O
small 11 16 2197 2202 B-chronic_disease
bowel 17 22 2203 2208 I-chronic_disease
resection 23 32 2209 2218 I-chronic_disease
( 33 34 2219 2220 O
except 34 40 2220 2226 O
if 41 43 2227 2229 O
related 44 51 2230 2237 O
to 52 54 2238 2240 O
appendectomy 55 67 2241 2253 B-treatment
) 67 68 2253 2254 O

Known 0 5 2255 2260 O
Type 6 10 2261 2265 B-chronic_disease
1 11 12 2266 2267 I-chronic_disease
Diabetes 13 21 2268 2276 I-chronic_disease

Male 0 4 2277 2281 B-gender

Non 0 3 2282 2285 O
- 3 4 2285 2286 O
diabetic 4 12 2286 2294 B-chronic_disease
subjects 13 21 2295 2303 O

Normoglycemic 0 13 2304 2317 B-clinical_variable
subjects 14 22 2318 2326 O
with 23 27 2327 2331 O
FPG 28 31 2332 2335 B-clinical_variable
≥90 32 35 2336 2339 O
milligram 36 45 2340 2349 I-lower_bound
( 46 47 2350 2351 I-lower_bound
mg)/deciliter 47 60 2351 2364 I-lower_bound
( 61 62 2365 2366 I-lower_bound
dL 62 64 2366 2368 I-lower_bound
) 64 65 2368 2369 I-lower_bound
and 66 69 2370 2373 O
< 70 71 2374 2375 O
100 71 74 2375 2378 B-upper_bound
mg 75 77 2379 2381 I-upper_bound
/ 77 78 2381 2382 I-upper_bound
dL 78 80 2382 2384 I-upper_bound
[ 81 82 2385 2386 O
≥5.0millimole 82 95 2386 2399 O
( 96 97 2400 2401 I-lower_bound
mmol)/liter 97 108 2401 2412 I-lower_bound
( 109 110 2413 2414 I-lower_bound
L 110 111 2414 2415 I-lower_bound
) 111 112 2415 2416 I-lower_bound
and 113 116 2417 2420 O
< 117 118 2421 2422 O
5.6 118 121 2422 2425 B-upper_bound
mmol 122 126 2426 2430 I-upper_bound
/ 126 127 2430 2431 I-upper_bound
L 127 128 2431 2432 I-upper_bound
] 128 129 2432 2433 O
at 130 132 2434 2436 O
both 133 137 2437 2441 O
Screening 138 147 2442 2451 O
Visits 148 154 2452 2458 O
with 155 159 2459 2463 O
HbA1c 160 165 2464 2469 B-clinical_variable
< 166 167 2470 2471 O
5.7 167 170 2471 2474 B-upper_bound
% 170 171 2474 2475 I-upper_bound
( 172 173 2476 2477 O
< 173 174 2477 2478 O
39 174 176 2478 2480 B-upper_bound
mmol 177 181 2481 2485 I-upper_bound
/ 181 182 2485 2486 I-upper_bound
mol 182 185 2486 2489 I-upper_bound
) 185 186 2489 2490 O

Positive 0 8 2491 2499 O
test 9 13 2500 2504 O
for 14 17 2505 2508 O
drugs 18 23 2509 2514 O
of 24 26 2515 2517 O
abuse 27 32 2518 2523 O
in 33 35 2524 2526 O
the 36 39 2527 2530 O
urine 40 45 2531 2536 O
Any 46 49 2537 2540 O
relevant 50 58 2541 2549 O
biochemical 59 70 2550 2561 O
abnormality 71 82 2562 2573 O
interfering 83 94 2574 2585 O
with 95 99 2586 2590 O
the 100 103 2591 2594 O
assessments 104 115 2595 2606 O
of 116 118 2607 2609 O
Gelesis200 119 129 2610 2620 B-treatment
Anti 130 134 2621 2625 I-treatment
- 134 135 2625 2626 I-treatment
obesity 135 142 2626 2633 I-treatment
medications 143 154 2634 2645 I-treatment
( 155 156 2646 2647 O
including 156 165 2647 2656 O
herbal 166 172 2657 2663 O
preparations 173 185 2664 2676 O
) 185 186 2676 2677 O
within 187 193 2678 2684 O
one(1 194 199 2685 2690 B-upper_bound
) 199 200 2690 2691 I-upper_bound
month 201 206 2692 2697 I-upper_bound
prior 207 212 2698 2703 I-upper_bound
to 213 215 2704 2706 O
Screening 216 225 2707 2716 O
Visit 226 231 2717 2722 O

Prediabetic 0 11 2723 2734 O
subjects 12 20 2735 2743 O
with 21 25 2744 2748 O
FPG≥100 26 33 2749 2756 B-clinical_variable
mg 34 36 2757 2759 I-lower_bound
/ 36 37 2759 2760 I-lower_bound
dL 37 39 2760 2762 I-lower_bound
and 40 43 2763 2766 O
< 44 45 2767 2768 O
126mg 45 50 2768 2773 B-upper_bound
/ 50 51 2773 2774 I-upper_bound
dL 51 53 2774 2776 I-upper_bound
[ 54 55 2777 2778 O
≥5.6 55 59 2778 2782 O
millimole 60 69 2783 2792 I-lower_bound
( 70 71 2793 2794 I-lower_bound
mmol)/liter 71 82 2794 2805 I-lower_bound
( 83 84 2806 2807 I-lower_bound
L 84 85 2807 2808 I-lower_bound
) 85 86 2808 2809 I-lower_bound
and 87 90 2810 2813 O
< 91 92 2814 2815 O
7.0mmol 92 99 2815 2822 B-upper_bound
/ 99 100 2822 2823 I-upper_bound
L 100 101 2823 2824 I-upper_bound
] 101 102 2824 2825 O
at 103 105 2826 2828 O
both 106 110 2829 2833 O
Screening 111 120 2834 2843 O
Visits 121 127 2844 2850 O
with 128 132 2851 2855 O
HbA1c 133 138 2856 2861 B-clinical_variable
≤6.4%[≤46 139 148 2862 2871 O
mmol 149 153 2872 2876 I-upper_bound
/ 153 154 2876 2877 I-upper_bound
mole 154 158 2877 2881 I-upper_bound
( 159 160 2882 2883 I-upper_bound
mol 160 163 2883 2886 I-upper_bound
) 163 164 2886 2887 I-upper_bound
] 164 165 2887 2888 O

Pregnancy 0 9 2889 2898 B-pregnancy

Serum 0 5 2899 2904 B-clinical_variable
low 6 9 2905 2908 I-clinical_variable
- 9 10 2908 2909 I-clinical_variable
density 10 17 2909 2916 I-clinical_variable
lipoprotein 18 29 2917 2928 I-clinical_variable
( 30 31 2929 2930 I-clinical_variable
LDL 31 34 2930 2933 I-clinical_variable
) 34 35 2933 2934 I-clinical_variable
cholesterol≥160mg 36 53 2935 2952 I-clinical_variable
/ 53 54 2952 2953 I-lower_bound
dL 54 56 2953 2955 I-lower_bound
( 57 58 2956 2957 O
≥4.15mmol 58 67 2957 2966 O
/ 67 68 2966 2967 I-lower_bound
L 68 69 2967 2968 I-lower_bound
) 69 70 2968 2969 O

Serum 0 5 2970 2975 B-clinical_variable
triglycerides 6 19 2976 2989 I-clinical_variable
≥350 20 24 2990 2994 O
mg 25 27 2995 2997 I-lower_bound
/ 27 28 2997 2998 I-lower_bound
dL 28 30 2998 3000 I-lower_bound
( 31 32 3001 3002 O
≥3.96mmol 32 41 3002 3011 O
/ 41 42 3011 3012 I-lower_bound
L 42 43 3012 3013 I-lower_bound
) 43 44 3013 3014 O

Smoking 0 7 3015 3022 O
cessation 8 17 3023 3032 O
within 18 24 3033 3039 O
six(6 25 30 3040 3045 B-upper_bound
) 30 31 3045 3046 I-upper_bound
months 32 38 3047 3053 I-upper_bound
prior 39 44 3054 3059 I-upper_bound
to 45 47 3060 3062 O
Screening 48 57 3063 3072 O
Visit 58 63 3073 3078 O
or 64 66 3079 3081 O
considering 67 78 3082 3093 O
smoking 79 86 3094 3101 O
cessation 87 96 3102 3111 O
during 97 103 3112 3118 O
the 104 107 3119 3122 O
study 108 113 3123 3128 O

Supine 0 6 3129 3135 B-clinical_variable
systolic 7 15 3136 3144 I-clinical_variable
blood 16 21 3145 3150 I-clinical_variable
pressure 22 30 3151 3159 I-clinical_variable
( 31 32 3160 3161 I-clinical_variable
SBP 32 35 3161 3164 I-clinical_variable
) 35 36 3164 3165 I-clinical_variable
> 37 38 3166 3167 O
160 38 41 3167 3170 B-lower_bound
millimeters 42 53 3171 3182 I-lower_bound
of 54 56 3183 3185 I-lower_bound
mercury 57 64 3186 3193 I-lower_bound
( 65 66 3194 3195 I-lower_bound
mmHg)and 66 74 3195 3203 I-lower_bound
/ 74 75 3203 3204 O
or 75 77 3204 3206 O
supine 78 84 3207 3213 B-clinical_variable
diastolic 85 94 3214 3223 I-clinical_variable
blood 95 100 3224 3229 I-clinical_variable
pressure(DBP 101 113 3230 3242 I-clinical_variable
) 113 114 3242 3243 I-clinical_variable
> 115 116 3244 3245 O
95mmHg 116 122 3245 3251 B-lower_bound

Systemic 0 8 3252 3260 B-treatment
corticosteroids 9 24 3261 3276 I-treatment
within 25 31 3277 3283 O
one 32 35 3284 3287 B-upper_bound
( 36 37 3288 3289 I-upper_bound
1 37 38 3289 3290 I-upper_bound
) 38 39 3290 3291 I-upper_bound
month 40 45 3292 3297 I-upper_bound
prior 46 51 3298 3303 I-upper_bound
to 52 54 3304 3306 O
Screening 55 64 3307 3316 O
Visit 65 70 3317 3322 O

Thyroid 0 7 3323 3330 O
hormones 8 16 3331 3339 O
or 17 19 3340 3342 O
preparations 20 32 3343 3355 O
within 33 39 3356 3362 O
one 40 43 3363 3366 B-upper_bound
( 44 45 3367 3368 I-upper_bound
1 45 46 3368 3369 I-upper_bound
) 46 47 3369 3370 I-upper_bound
month 48 53 3371 3376 I-upper_bound
prior 54 59 3377 3382 I-upper_bound
to 60 62 3383 3385 O
Screening 63 72 3386 3395 O
Visit 73 78 3396 3401 O
[ 79 80 3402 3403 O
except 80 86 3403 3409 O
stable 87 93 3410 3416 O
dose 94 98 3417 3421 O
of 99 101 3422 3424 O
replacement 102 113 3425 3436 B-treatment
therapy 114 121 3437 3444 I-treatment
for 122 125 3445 3448 O
at 126 128 3449 3451 O
least 129 134 3452 3457 O
two(2 135 140 3458 3463 B-lower_bound
) 140 141 3463 3464 I-lower_bound
months 142 148 3465 3471 I-lower_bound
] 148 149 3471 3472 O

Untreated 0 9 3473 3482 O
subjects 10 18 3483 3491 O
with 19 23 3492 3496 O
FPG 24 27 3497 3500 B-clinical_variable
≤200 28 32 3501 3505 O
mg 33 35 3506 3508 I-upper_bound
/ 35 36 3508 3509 I-upper_bound
dL 36 38 3509 3511 I-upper_bound
( 39 40 3512 3513 O
≤11.2 40 45 3513 3518 O
mmol 46 50 3519 3523 I-upper_bound
/ 50 51 3523 3524 I-upper_bound
L)at 51 55 3524 3528 I-upper_bound
both 56 60 3529 3533 O
Screening 61 70 3534 3543 O
Visits 71 77 3544 3550 O
and 78 81 3551 3554 O
either 82 88 3555 3561 O
FPG 89 92 3562 3565 O
≥126 93 97 3566 3570 O
mg 98 100 3571 3573 O
/ 100 101 3573 3574 O
dL 101 103 3574 3576 O
( 104 105 3577 3578 O
≥7.0 105 109 3578 3582 O
mmol 110 114 3583 3587 O
/ 114 115 3587 3588 O
L 115 116 3588 3589 O
) 116 117 3589 3590 O
at 118 120 3591 3593 O
both 121 125 3594 3598 O
Screening 126 135 3599 3608 O
Visits 136 142 3609 3615 O
or 143 145 3616 3618 O
FPG 146 149 3619 3622 O
< 150 151 3623 3624 O
126 151 154 3624 3627 O
mg 155 157 3628 3630 O
/ 157 158 3630 3631 O
dL 158 160 3631 3633 O
( 161 162 3634 3635 O
< 162 163 3635 3636 O
7.0 163 166 3636 3639 O
mmol 167 171 3640 3644 O
/ 171 172 3644 3645 O
L 172 173 3645 3646 O
) 173 174 3646 3647 O
at 175 177 3648 3650 O
one 178 181 3651 3654 O
( 182 183 3655 3656 O
1 183 184 3656 3657 O
) 184 185 3657 3658 O
or 186 188 3659 3661 O
both 189 193 3662 3666 O
Screening 194 203 3667 3676 O
Visits 204 210 3677 3683 O
with 211 215 3684 3688 O
HbA1c 216 221 3689 3694 B-clinical_variable
≥6.5 222 226 3695 3699 O
% 226 227 3699 3700 I-lower_bound
( 228 229 3701 3702 O
≥48 229 232 3702 3705 O
mmol 233 237 3706 3710 I-lower_bound
/ 237 238 3710 3711 I-lower_bound
mol 238 241 3711 3714 I-lower_bound
) 241 242 3714 3715 O

adequately 0 10 3716 3726 O
- 10 11 3726 3727 O
treated 11 18 3727 3734 O
localized 19 28 3735 3744 O
basal 29 34 3745 3750 B-cancer
cell 35 39 3751 3755 I-cancer
skin 40 44 3756 3760 I-cancer
cancer 45 51 3761 3767 I-cancer
or 52 54 3768 3770 O
in 55 57 3771 3773 O
situuterine 58 69 3774 3785 O
cervical 70 78 3786 3794 B-cancer
cancer 79 85 3795 3801 I-cancer

female 0 6 3802 3808 B-gender

if 0 2 3809 3811 O
only 3 7 3812 3816 O
one 8 11 3817 3820 O
( 12 13 3821 3822 O
1)value 13 20 3822 3829 O
is 21 23 3830 3832 O
within 24 30 3833 3839 O
this 31 35 3840 3844 O
range 36 41 3845 3850 O
, 41 42 3850 3851 O
the 43 46 3852 3855 O
other 47 52 3856 3861 O
value 53 58 3862 3867 O
should 59 65 3868 3874 O
not 66 69 3875 3878 O
be 70 72 3879 3881 O
≥126mg 73 79 3882 3888 O
/ 79 80 3888 3889 I-lower_bound
dL 80 82 3889 3891 I-lower_bound
( 83 84 3892 3893 O
≥7.0mmol 84 92 3893 3901 O
/ 92 93 3901 3902 I-lower_bound
L 93 94 3902 3903 I-lower_bound
) 94 95 3903 3904 O
and 96 99 3905 3908 O
HbA1c 100 105 3909 3914 B-clinical_variable
should 106 112 3915 3921 O
be 113 115 3922 3924 O
≥5.7 116 120 3925 3929 O
% 120 121 3929 3930 I-lower_bound
( 122 123 3931 3932 O
≥39 123 126 3932 3935 O
mmol 127 131 3936 3940 I-lower_bound
/ 131 132 3940 3941 I-lower_bound
mol 132 135 3941 3944 I-lower_bound
) 135 136 3944 3945 O
and 137 140 3946 3949 O
≤6.4%(≤46 141 150 3950 3959 O
mmol 151 155 3960 3964 I-upper_bound
/ 155 156 3964 3965 I-upper_bound
mol 156 159 3965 3968 I-upper_bound
) 159 160 3968 3969 O

positive 0 8 3970 3978 B-pregnancy
serum 9 14 3979 3984 I-pregnancy
or 15 17 3985 3987 I-pregnancy
urine 18 23 3988 3993 I-pregnancy
pregnancy 24 33 3994 4003 I-pregnancy
test(s 34 40 4004 4010 O
) 40 41 4010 4011 O
in 42 44 4012 4014 O
females 45 52 4015 4022 B-gender
of 53 55 4023 4025 O
childbearing 56 68 4026 4038 O
potential 69 78 4039 4048 O

